Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,031 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ocular inflammation in Behçet disease: incidence of ocular complications and of loss of visual acuity.
Kaçmaz RO, Kempen JH, Newcomb C, Gangaputra S, Daniel E, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Foster CS; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Group. Kaçmaz RO, et al. Among authors: foster cs. Am J Ophthalmol. 2008 Dec;146(6):828-36. doi: 10.1016/j.ajo.2008.06.019. Epub 2008 Aug 16. Am J Ophthalmol. 2008. PMID: 18708181 Free PMC article.
Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial.
Gangaputra SS, Altaweel MM, Peng Q, Friedman DS, Rao PK, Foster CS, Kim RY, Reed SB, Srivastava SK, Wong IG, Kempen JH; MUST Trial Research Group. Gangaputra SS, et al. Among authors: foster cs. Ocul Immunol Inflamm. 2011 Aug;19(4):267-74. doi: 10.3109/09273948.2011.583376. Ocul Immunol Inflamm. 2011. PMID: 21770805 Free PMC article. Clinical Trial.
Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema.
Levin MH, Pistilli M, Daniel E, Gangaputra SS, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study. Levin MH, et al. Among authors: foster cs. Ophthalmology. 2014 Feb;121(2):588-95.e1. doi: 10.1016/j.ophtha.2013.09.023. Epub 2013 Dec 12. Ophthalmology. 2014. PMID: 24332536 Free PMC article.
Cost-effectiveness of fluocinolone acetonide implant versus systemic therapy for noninfectious intermediate, posterior, and panuveitis.
Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group; Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD. Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, et al. Ophthalmology. 2014 Oct;121(10):1855-62. doi: 10.1016/j.ophtha.2014.04.022. Epub 2014 Jun 5. Ophthalmology. 2014. PMID: 24908205 Free PMC article. Clinical Trial.
Outcomes of Intravenous Tocilizumab Treatment for Refractory Pars Planitis.
Kongrat L, Maleki A, Rujkorakarn P, Margolis MJ, Valerio T, Massoudi Y, Anesi SD, Foster CS. Kongrat L, et al. Among authors: foster cs. Ocul Immunol Inflamm. 2024 May 23:1-6. doi: 10.1080/09273948.2024.2354751. Online ahead of print. Ocul Immunol Inflamm. 2024. PMID: 38781578
Clinical Course and Outcomes of Autoimmune Versus Non-Autoimmune Surgically Induced Scleral Necrosis: A Multicentric Comparative Study.
Ruiz-Lozano RE, Ramos-Dávila EM, Colorado-Zavala MF, Quiroga-Garza ME, Azar NS, Mousa HM, Perez VL, Sainz-de-la-Maza M, Foster CS, Rodriguez-Garcia A. Ruiz-Lozano RE, et al. Among authors: foster cs. Ocul Immunol Inflamm. 2024 May 17:1-7. doi: 10.1080/09273948.2024.2349914. Online ahead of print. Ocul Immunol Inflamm. 2024. PMID: 38759224
1,031 results